LabCompass

Publications

48

Citations

904

Est. group size

Recurring co-author estimate

Active years

17

Publishing since 2010

Research summary
AI-generated

Kevin A. Maupin studies the biology of bone and cancer using molecular and imaging approaches. Earlier work examined how specific genes and glycan-binding proteins (such as galectin-3) affect bone mass and structure in mice, while more recent projects focus on nuclear-medicine imaging and radioligand therapies for prostate, pancreatic, and other cancers, as well as data-driven analysis of skeletal traits and fracture risk.

Bone biology and skeletal phenotypesCancer imaging (PET/CT) and radioligand therapyGlycosylation and glycan-binding proteinsGene function in bone (mouse models)Causal analysis of fracture risk

Publication activity has been fairly steady at a low-to-moderate level over the past decade, peaking around 2019 and averaging about two papers per year in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
2017: 3 publications172018: 3 publications182019: 7 publications7192020: 3 publications202021: 3 publications212022: 3 publications222023: 1 publication232024: 2 publications242025: 2 publications252026: 2 publications26
Recent publications
Publishes in
  • PMC×4
  • Bone×3
  • npj Microgravity×2
  • Journal of Clinical Oncology×2
  • Cureus×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile